For those unsure when Chong vaguely rambles on about Accelerated approval & Ph2/3 registrational trial and what it mean this is what she is talking about in clear picture form.
note the benchmarks categories in diagram 2 and apply that to Azer-cel and it's target patients
not x-promo PTX and especially their ex-CEO Yatomi-Clarke have always been able to present this stuff better than Chong could ever hope to.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.010(3.57%) |
Mkt cap ! $77.89M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 26.3¢ | $1.990M | 7.367M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 209631 | 9 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |